Content about Watson

November 19, 2012
Generic Drug Report 2012

The year 2012 is coming to an end, and it's been a big year for generic drugs. It's the year that the most lucrative drug of all time became commoditized. It's the year that Watson bought Actavis for $5.6 billion. And it's the year the FDA released draft guidance for biosimilars regulations. All of these events speak to some of the most important trends in the world of generics — trends that are often interrelated.

January 9, 2013
Watson appoints former GPhA executive as VP government affairs

Generic drug maker Watson Pharmaceuticals has hired a former executive from the Generic Pharmaceutical Association to head lobbying at the federal and state level, the company said.

November 13, 2012
Towers Watson names Loblaw Companies preferred pharmacy for Towers Watson Canadian Rx Coalition

Towers Watson on Tuesday announced that it has selected Loblaw Companies as the preferred pharmacy services provider for its Towers Watson Canadian Rx Coalition, a collaborative network of private sector drug plan sponsors.

November 1, 2012
Watson to change brand in 2013

Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.

October 8, 2012
European Commission approves Watson-Actavis merger

European regulators have approved U.S. drug maker Watson's acquisition of Switzerland-based Actavis, Watson said.

June 28, 2012
Mylan joins patent challenge on Pfizer antidepressant drug

Mylan is challenging the patent protection on a Pfizer drug for treating depression, following an announcement of a similar challenge by Watson made earlier this week.

May 16, 2012
ReportersNotebook — Chain Pharmacy, 5/21/12

Watson has announced its intention to acquire Actavis, the company said. Following news reports that the U.S.-based generic drug maker would acquire Switzerland-based Actavis, Watson announced that it would buy the latter for $5.6 billion.

April 26, 2012
Watson to buy Actavis for $5.6 billion

Watson has announced its intention to acquire Actavis, the company said.

April 3, 2012
Watson seeks approval for generic Lumigan, Latisse

Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday.

September 12, 2011
Dr. 2.0: WellPoint uses IBM Watson technology to develop healthcare applications

Healthcare giant WellPoint has inked a deal with IBM whereby it will develop applications using IBM's Watson artificial intelligence technology to deliver healthcare information to patients.

September 12, 2011
Pharma faces its own hurricane season

At press time, Hurricane Irene was slowly barreling toward the East Coast and threatening the area with a deluge that prompted cities to shut down and had store shelves wiped clean.


March 25, 2011
Court: Watson's generic Fentora infringes on branded counterpart

A generic painkiller made by Watson Pharmaceuticals infringes a patent covering the branded version, a U.S. District Court ruled.

March 9, 2011
Watson promotes two SVPs

Generic drug maker Watson Pharmaceuticals has promoted two executives to EVP, the company said Wednesday.

May 31, 2010
Columbia Labs files definitive proxy relating to Watson deal

Columbia Labs is seeking shareholder approval for an agreement in which Watson would acquire the...

March 9, 2010
Watson reaches patent settlement for Actos generic

MORRISTOWN, N.J. Watson Pharmaceuticals and Takeda Pharmaceuticals North America have settled a patent litigation case...

March 8, 2010
Watson seeks approval for generic Opana

Watson Pharmaceuticals has filed a regulatory approval application for a generic version of a painkiller...

January 31, 2010
Watson to become commercial partner for emergency contraceptive

Watson Pharmaceuticals and HRA Pharma have signed a deal whereby Watson will become the commercial...

© 2013 Drug Store News. All Rights Reserved.